In vivo assessment of black seed oil single dose on prednisolone pharmacokinetics.

black seed interactions herb–drug interactions p-gp inhibition prednisolone pharmacokinetics

Journal

The Journal of pharmacy and pharmacology
ISSN: 2042-7158
Titre abrégé: J Pharm Pharmacol
Pays: England
ID NLM: 0376363

Informations de publication

Date de publication:
18 Nov 2023
Historique:
received: 28 08 2023
accepted: 07 11 2023
medline: 18 11 2023
pubmed: 18 11 2023
entrez: 18 11 2023
Statut: aheadofprint

Résumé

To investigate the effect of blackseed oil (BSO) single dose on prednisolone pharmacokinetics via p-gp inhibition. Three groups of rats (n = 5) were orally administered the vehicle, verapamil (50 mg/kg) or BSO (5 ml/kg) 15 min prior to prednisolone (5 mg/kg) administration. Blood samples were collected over 24 h and quantified. Non-compartmental analysis was employed to calculate maximum plasma concentration (Cmax), area under the curve (AUC0-last), time to reach Cmax (Tmax), apparent clearance (CL/F), and half-life (t1/2). Statistical significance was considered at p<0.05. Prednisolone Cmax and AUC0-last decreased by 65% and 25% in the BSO group compared to the negative control (P < .0001, .0029, respectively) while they increased by 1.75-folds and 8-folds in verapamil group (P < .0001). Tmax was achieved at 0.16, 0.5, and 0.25 h in the negative control, verapamil, and BSO-treated groups, respectively. CL/F in the treatment group was 1.3-fold and 10-fold higher compared to the negative and positive control, respectively, whereas the t1/2 remained comparable. Administration of BSO decreased prednisolone Cmax and AUC0-last in rats indicating that there is a herb-drug interaction; however, p-gp inhibition cannot be concluded. Patients relying on folk medicine in chronic illnesses treatment might need to avoid combining BSO with prednisolone.

Identifiants

pubmed: 37978932
pii: 7428706
doi: 10.1093/jpp/rgad110
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : Zarqa University
ID : RGP2/195/44
Organisme : King Khalid University

Informations de copyright

© The Author(s) 2023. Published by Oxford University Press on behalf of the Royal Pharmaceutical Society.

Auteurs

Rana Abutaima (R)

Faculty of Pharmacy, Zarqa University, Zarqa, Jordan.

Yousef Al-Ebini (Y)

Department of Cosmetic Science, Faculty of Allied Medical Sciences, Al-Ahliyya Amman University, Amman 19328, Jordan.
Faculty of Dentistry, Al-Ahliyya Amman University, Amman 19328, Jordan.

Ahmad Alkofahi (A)

Faculty of Pharmacy, Jordan University of Science and Technology, Irbid, Jordan.

Anas Alshishani (A)

Faculty of Pharmacy, Zarqa University, Zarqa, Jordan.

Samar Thiab (S)

Faculty of Pharmacy, Applied Science Private University, Amman, Jordan.

Kumarappan C Alagammai (KC)

Faculty of Pharmacy, King Khaled University, Abha, Kingdom of Saudi Arabia.

Mohammad Khalid (M)

Department of Pharmaceutics, College of Pharmacy, King Khalid University, Asir-Abha 61421, Saudi Arabia.

Classifications MeSH